167 related articles for article (PubMed ID: 25737008)
21. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
22. Anti-HBV active constituents from Piper longum.
Jiang ZY; Liu WF; Zhang XM; Luo J; Ma YB; Chen JJ
Bioorg Med Chem Lett; 2013 Apr; 23(7):2123-7. PubMed ID: 23434420
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q
Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
[TBL] [Abstract][Full Text] [Related]
26. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
29. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.
Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K
Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737
[TBL] [Abstract][Full Text] [Related]
30. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging.
Dai JJ; Tao HM; Min QX; Zhu QH
Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758
[TBL] [Abstract][Full Text] [Related]
31. Schisanwilsonenes A-C, anti-HBV Carotane sesquiterpenoids from the fruits of Schisandra wilsoniana.
Ma WH; Huang H; Zhou P; Chen DF
J Nat Prod; 2009 Apr; 72(4):676-8. PubMed ID: 19228000
[TBL] [Abstract][Full Text] [Related]
32. Chemical constituents of Swertia mussotii and their anti-hepatitis B virus activity.
Cao TW; Geng CA; Ma YB; Zhang XM; Zhou J; Tao YD; Chen JJ
Fitoterapia; 2015 Apr; 102():15-22. PubMed ID: 25665940
[TBL] [Abstract][Full Text] [Related]
33. A coumarin lignanoid from the stems of Kadsura heteroclita.
Su W; Zhao J; Yang M; Yan HW; Pang T; Chen SH; Huang HY; Zhang SH; Ma XC; Guo DA; Khan IA; Wang W
Bioorg Med Chem Lett; 2015 Apr; 25(7):1506-8. PubMed ID: 25736995
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
[TBL] [Abstract][Full Text] [Related]
35. Diterpenes from buds of Wikstroemia chamaedaphne showing anti-hepatitis B virus activities.
Li SF; Jiao YY; Zhang ZQ; Chao JB; Jia J; Shi XL; Zhang LW
Phytochemistry; 2018 Jul; 151():17-25. PubMed ID: 29631103
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors.
Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X
Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
[TBL] [Abstract][Full Text] [Related]
38. Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity.
Wan CX; Zhang PH; Luo JG; Kong LY
J Nat Prod; 2011 Apr; 74(4):683-9. PubMed ID: 21401115
[TBL] [Abstract][Full Text] [Related]
39. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
[TBL] [Abstract][Full Text] [Related]
40. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
